Gain Therapeutics to Participate in AI Driven Drug Discovery Summit
29 Noviembre 2023 - 7:00AM
Gain Therapeutics, Inc., (Nasdaq: GANX), a clinical-stage
biotechnology company leading the discovery and development of the
next generation of allosteric small molecule therapies, today
announced that Matthias Alder, Chief Executive Officer, will
participate on a panel during the AI Driven Drug Discovery Summit
taking place at the Sheraton Boston Hotel, in Boston, Massachusetts
December 5-6, 2023.
AI Driven Drug Discovery
SummitDate: Wednesday, December 6, 2023Time: 4:30 p.m.
ESTFormat: Panel Discussion – Collaboration is Key to Enhancing
AI-Driven Drug Discovery
To register for the event, please click here.
About Gain Therapeutics, Inc.
Gain Therapeutics, Inc. is a clinical-stage
biotechnology company leading the discovery and development of next
generation allosteric therapies. Gain’s lead drug candidate
GT-02287, in development for the treatment of GBA1 Parkinson’s
disease, is currently being evaluated in a Phase 1 clinical
trial.
Leveraging AI-supported structural biology,
proprietary algorithms and supercomputer-powered physics-based
models, the company’s SEE-Tx® discovery platform can identify novel
allosteric binding sites on disease-implicated proteins,
pinpointing pockets that cannot be found or drugged with current
technologies. Gain’s unique approach enables the discovery of
novel, allosteric small molecule modulators that can restore or
disrupt protein function. Deploying its highly advanced platform,
Gain is accelerating drug discovery and unlocking novel
disease-modifying treatments for untreatable or difficult-to-treat
disorders including neurodegenerative diseases, rare genetic
disorders and oncology. For more information, please
visit GainTherapeutics.com and follow us on LinkedIn.
Investor & Media Contact:
Susan SharpeLinnden Communications(919)
602-2330susan@linndencom.com
Gain Therapeutics (NASDAQ:GANX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Gain Therapeutics (NASDAQ:GANX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024